Skip to main content

Advertisement

Log in

Identification of novel HLA-A0201-restricted T-cell epitopes against thyroid antigens in autoimmune thyroid diseases

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The different mechanisms that trigger the autoimmune attack to the thyroid between Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are still unclear. The aim of this study was to recognize thyroid antigens specific CD8+ T-cell epitopes and explore the relationship between these epitopes and thyroid autoantibodies, duration and classification in these two diseases.

Methods

Free thiiodothyronine, free tetraiodothyronine, thyroid-stimulating hormone, TgAb, and TPOAb were all measured by immunochemiluminometric assays, while TRAb was tested by radioimmunoassay. HLA class I peptide affinity algorithms were applied to predict candidate thyroid autoantigen peptides that blind to HLA-A*0201. The ELISpot assay was used to detect Tg-, TPO-, and TSHR-specific CD8+ T cells.

Results

We demonstrated that TG-6 was a novel HLA-A*0201-restricted CTL epitope in GD. TG-6, TG-7, TG-10, TG-11, and TPO-6 were immunodominant in GD patients compared with HT patients (TG-6: 38.5 vs. 8%, P = 0.034; TG-7, TG-10, TG-11, and TPO-6: 23.1 vs. 0%, P = 0.034). The immunodominance of TG-6 in GD patients was more evident than healthy controls (HC) (TG-6: 35.8 vs. 0%, P = 0.011), but there was no statistically significant difference between HT patients and HC. Subgroup analyses revealed the T-cell responsiveness to TG-6 was stronger in TgAb-negative HT patients (0 vs. 40%, P = 0.033). However, there was no correlation showed for TPOAb, TRAb, medication and duration in both HT and GD patients.

Conclusions

We report for the first time that both diseases, HT and GD, recognize different antigen-specific CD8-positive T cells. Tg maybe the dominant thyroid autoantigen contributing to breaking tolerance in GD. It could improve our knowledge of autoimmune thyroid diseases pathogenesis as well as offer new therapeutical tools in terms of peptide vaccine therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. A. Antonelli, S.M. Ferrari, A. Corrado, A. Di Domenicantonio, P. Fallahi, Autoimmune thyroid disorders. Autoimmun. Rev. 14(2), 174–180 (2015). https://doi.org/10.1016/j.autrev.2014.10.016

    Article  CAS  PubMed  Google Scholar 

  2. H.B. Burch, D.S. Cooper, Management of Graves disease: a review. JAMA 314(23), 2544–2554 (2015). https://doi.org/10.1001/jama.2015.16535

    Article  CAS  PubMed  Google Scholar 

  3. M. Rydzewska, M. Jaromin, I.E. Pasierowska, K. Stozek, A. Bossowski, Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 11, 2 (2018). https://doi.org/10.1186/s13044-018-0046-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. G.P. Leese, R.V. Flynn, R.T. Jung, T.M. Macdonald, M.J. Murphy, A.D. Morris, Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin. Endocrinol. 68(2), 311–316 (2008). https://doi.org/10.1111/j.1365-2265.2007.03051.x

    Article  CAS  Google Scholar 

  5. S. De Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet 388(10047), 906–918 (2016). https://doi.org/10.1016/S0140-6736(16)00278-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. J.A. Franklyn, K. Boelaert, Thyrotoxicosis. Lancet 379(9821), 1155–1166 (2012). https://doi.org/10.1016/S0140-6736(11)60782-4

    Article  CAS  PubMed  Google Scholar 

  7. S.M. McLachlan, B. Rapoport, Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr. Rev. 35(1), 59–105 (2014). https://doi.org/10.1210/er.2013-1055

    Article  CAS  PubMed  Google Scholar 

  8. A.M. Ramos-Levi, M. Marazuela, Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol. Nutr. 63(8), 421–429 (2016). https://doi.org/10.1016/j.endonu.2016.04.003

    Article  PubMed  Google Scholar 

  9. H. Mikos, M. Mikos, M. Obara-Moszynska, M. Niedziela, The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol. Pol. 65(2), 150–155 (2014). https://doi.org/10.5603/EP.2014.0021

    Article  PubMed  Google Scholar 

  10. T.J. Smith, L. Hegedus, Graves’ Disease. N. Engl. J. Med 375(16), 1552–1565 (2016). https://doi.org/10.1056/NEJMra1510030

    Article  PubMed  Google Scholar 

  11. L. Lamki, V.V. Row, R. Volpe, Cell-mediated immunity in Graves’ disease and in Hashimoto’s \thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J. Clin. Endocrinol. Metab. 36(2), 358–364 (1973). https://doi.org/10.1210/jcem-36-2-358

    Article  CAS  PubMed  Google Scholar 

  12. L.J. Guan, X. Wang, S. Meng, L.F. Shi, W.J. Jiang, L. Xiao, X.H. Shi, J. Xu, J.A. Zhang, Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 72(2), 160–165 (2015). https://doi.org/10.1016/j.cyto.2014.11.005

    Article  CAS  PubMed  Google Scholar 

  13. F. Menconi, A. Huber, R. Osman, E. Concepcion, E.M. Jacobson, M. Stefan, C.S. David, Y. Tomer, Tg.2098 is a major human thyroglobulin T-cell epitope. J. Autoimmun. 35(1), 45–51 (2010). https://doi.org/10.1016/j.jaut.2010.01.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. C.W. Li, F. Menconi, R. Osman, M. Mezei, E.M. Jacobson, E. Concepcion, C.S. David, D.B. Kastrinsky, M. Ohlmeyer, Y. Tomer, Identifying a small molecule blocking antigen presentation in autoimmune thyroiditis. J. Biol. Chem. 291(8), 4079–4090 (2016). https://doi.org/10.1074/jbc.M115.694687

    Article  CAS  PubMed  Google Scholar 

  15. Q. Deng, Y. Luo, C. Chang, H. Wu, Y. Ding, R. Xiao, The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review. Front Immunol. 10, 856 (2019). https://doi.org/10.3389/fimmu.2019.00856

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. M. Limbach, M. Saare, L. Tserel, K. Kisand, T. Eglit, S. Sauer, T. Axelsson, A.C. Syvanen, A. Metspalu, L. Milani, P. Peterson, Epigenetic profiling in CD4+ and CD8+ T cells from Graves’ disease patients reveals changes in genes associated with T cell receptor signaling. J. Autoimmun. 67, 46–56 (2016). https://doi.org/10.1016/j.jaut.2015.09.006

    Article  CAS  PubMed  Google Scholar 

  17. Z. Sun, W. Zhong, X. Lu, B. Shi, Y. Zhu, L. Chen, G. Zhang, X. Zhang, Association of Graves’ disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J. Clin. Immunol. 28(5), 464–472 (2008). https://doi.org/10.1007/s10875-008-9213-4

    Article  CAS  PubMed  Google Scholar 

  18. M. Ehlers, A. Thiel, C. Bernecker, D. Porwol, C. Papewalis, H.S. Willenberg, S. Schinner, H. Hautzel, W.A. Scherbaum, M. Schott, Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 97(4), 1347–1354 (2012). https://doi.org/10.1210/jc.2011-2178

    Article  CAS  PubMed  Google Scholar 

  19. S. Allelein, A. Kuebart, M. Haase, T. Dringenberg, C. Schmid, M. Schott, M. Ehlers, Measurement of TSH receptor epitope-specific T cells in Graves’ disease. Horm. Metab. Res. 48(12), 862–864 (2016). https://doi.org/10.1055/s-0042-120846

    Article  CAS  PubMed  Google Scholar 

  20. S. Cote-Bigras, A. Dionne, P. Asselin-Mullen, C. Leblicq, D. Rottembourg, Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves’ disease. Clin. Endocrinol. 80(2), 296–300 (2014). https://doi.org/10.1111/cen.12257

    Article  CAS  Google Scholar 

  21. K. Parker, M. Bednarek, J. Coligan, Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152(1), 163–175 (1994)

    CAS  PubMed  Google Scholar 

  22. C. Lundegaard, K. Lamberth, M. Harndahl, S. Buus, O. Lund, M. Nielsen, NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36(Web Server issue), W509–W512 (2008). https://doi.org/10.1093/nar/gkn202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. X. Xu, Y. Gu, L. Bian, Y. Shi, Y. Cai, Y. Chen, H. Chen, L. Qian, X. Wu, K. Xu, R. Mallone, H.W. Davidson, L. Yu, J. She, M. Zhang, T. Yang, Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes. Vaccine 34(6), 854–862 (2016). https://doi.org/10.1016/j.vaccine.2015.10.108

    Article  CAS  PubMed  Google Scholar 

  24. R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.M. Bach, P. van Endert, CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 56(3), 613–621 (2007). https://doi.org/10.2337/db06-1419

    Article  CAS  PubMed  Google Scholar 

  25. J.M. Ellis, V. Henson, R. Slack, J. Ng, R.J. Hartzman, C. Katovich Hurley, Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. Hum. Immunol. 61(3), 334–340 (2000). https://doi.org/10.1016/s0198-8859(99)00155-x

    Article  CAS  PubMed  Google Scholar 

  26. A. Di Cerbo, R. Di Paola, C. Menzaghi, V. De Filippis, K. Tahara, D. Corda, L.D. Kohn, Graves’ immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. J. Clin. Endocrinol. Metab. 84(9), 3283–3292 (1999). https://doi.org/10.1210/jcem.84.9.5967

    Article  PubMed  Google Scholar 

  27. C. Evans, N.G. Morgenthaler, S. Lee, D.H. Llewellyn, R. Clifton-Bligh, R. John, J.H. Lazarus, V.K. Chatterjee, M. Ludgate, Development of a luminescent bioassay for thyroid stimulating antibodies. J. Clin. Endocrinol. Metab. 84(1), 374–377 (1999). https://doi.org/10.1210/jcem.84.1.5532

    Article  CAS  PubMed  Google Scholar 

  28. H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015). https://doi.org/10.1016/j.jaut.2015.07.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. C.W. Li, R. Osman, F. Menconi, E.S. Concepcion, Y. Tomer, Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J. Autoimmun. 76, 1–9 (2017). https://doi.org/10.1016/j.jaut.2016.09.007

    Article  CAS  PubMed  Google Scholar 

  30. M. Soliman, E. Kaplan, A. Abdel-Latif, N. Scherberg, L.J. DeGroot, Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients’ T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases? J. Clin. Endocrinol. Metab. 80(8), 2312–2321 (1995). https://doi.org/10.1210/jcem.80.8.7543112

    Article  CAS  PubMed  Google Scholar 

  31. Y. Kawakami, M.E. Fisfalen, L.J. DeGroot, Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid diseases to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 13(1), 17–26 (1992). https://doi.org/10.3109/08916939209014631

    Article  CAS  PubMed  Google Scholar 

  32. M.E. Fisfalen, M. Soliman, Y. Okamoto, K. Soltani, L.J. DeGroot, Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 80(5), 1597–1604 (1995). https://doi.org/10.1210/jcem.80.5.7745006

    Article  CAS  PubMed  Google Scholar 

  33. C.M. Dayan, M. Londei, A.E. Corcoran, B. Grubeck-Loebenstein, R.F. James, B. Rapoport, M. Feldmann, Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl. Acad. Sci. USA 88(16), 7415–7419 (1991). https://doi.org/10.1073/pnas.88.16.7415

    Article  CAS  PubMed  Google Scholar 

  34. S. Quaratino, M. Feldmann, C.M. Dayan, O. Acuto, M. Londei, Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope. J. Exp. Med 183(2), 349–358 (1996). https://doi.org/10.1084/jem.183.2.349

    Article  CAS  PubMed  Google Scholar 

  35. E.A. James, M. Pietropaolo, M.J. Mamula, Immune recognition of beta-Cells: neoepitopes as key players in the loss of tolerance. Diabetes 67(6), 1035–1042 (2018). https://doi.org/10.2337/dbi17-0030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Z. Zhao, J. Ren, C. Dai, C.C. Kannapell, H. Wang, F. Gaskin, S.M. Fu, Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification. Ann. Rheum. Dis. 78(3), 380–390 (2019). https://doi.org/10.1136/annrheumdis-2018-214125

    Article  CAS  PubMed  Google Scholar 

  37. Y. Tomer, Y. Ban, E. Concepcion, G. Barbesino, R. Villanueva, D.A. Greenberg, T.F. Davies, Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73(4), 736–747 (2003). https://doi.org/10.1086/378588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. W. Ke, T. Sun, Y. Zhang, L. He, Q. Wu, J. Liu, B. Zha, 25-Hydroxyvitamin D serum level in Hashimoto’s thyroiditis, but not Graves’ disease is relatively deficient. Endocr. J. 64(6), 581–587 (2017). https://doi.org/10.1507/endocrj.EJ16-0547

    Article  CAS  PubMed  Google Scholar 

  39. S.A. Morshed, R. Latif, T.F. Davies, Delineating the autoimmune mechanisms in Graves’ disease. Immunol. Res. 54(1–3), 191–203 (2012). https://doi.org/10.1007/s12026-012-8312-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. B. Rapoport, S.M. McLachlan, Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J. Clin. Endocrinol. Metab. 99(11), 4060–4061 (2014). https://doi.org/10.1210/jc.2014-3011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. M.A. Fernandez-Vina, M. Falco, Y. Sun, P. Stastny, DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum. Immunol. 33(3), 163–173 (1992). https://doi.org/10.1016/0198-8859(92)90068-x

    Article  CAS  PubMed  Google Scholar 

  42. H. Park, Y.J. Lee, E.Y. Song, M.H. Park, HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea. Int J. Immunogenet. 43(5), 287–296 (2016). https://doi.org/10.1111/iji.12288

    Article  CAS  PubMed  Google Scholar 

  43. Y. Li, H.J. Bao, X. Qiu, Q. Yuan, X. Xu, C. Di, W. Zhang, J. Xu, Z.X. Chen, A study on allele frequencies and mismatching proportion of HLA-A,B,Cw,DRB1 and DQB1 on high-resolution donor-recipient typing in Chinese Han population. Chin. J. Med. Genet. 28(1), 7 (2011)

    CAS  Google Scholar 

  44. M. Pan, Z.X. Pan, Q. Fan, S. Wang, X. Wang, C. Shen J, Study on the analysis of high-resolution HLA-A, B and DRB1 alleles from 3238 hematopoietic stem cell donors in Jiangsu Han Chinese. Zhonghua Xue Ye Xue Za Zhi 33(2), 4 (2012)

    Google Scholar 

  45. L. Muixi, M. Carrascal, I. Alvarez, X. Daura, M. Marti, M.P. Armengol, C. Pinilla, J. Abian, R. Pujol-Borrell, D. Jaraquemada, Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J. Immunol. 181(1), 795–807 (2008). https://doi.org/10.4049/jimmunol.181.1.795

    Article  CAS  PubMed  Google Scholar 

  46. K. Sakai, S. Shirasawa, N. Ishikawa, K. Ito, H. Tamai, K. Kuma, T. Akamizu, M. Tanimura, K. Furugaki, K. Yamamoto, T. Sasazuki, Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet 10(13), 1379–1386 (2001). https://doi.org/10.1093/hmg/10.13.1379

    Article  CAS  PubMed  Google Scholar 

  47. Y. Tomer, D.A. Greenberg, E. Concepcion, Y. Ban, T.F. Davies, Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 87(1), 404–407 (2002). https://doi.org/10.1210/jcem.87.1.8291

    Article  CAS  PubMed  Google Scholar 

  48. S. Ueda, D. Oryoji, K. Yamamoto, J.Y. Noh, K. Okamura, M. Noda, K. Kashiwase, Y. Kosuga, K. Sekiya, K. Inoue, H. Yamada, A. Oyamada, Y. Nishimura, Y. Yoshikai, K. Ito, T. Sasazuki, Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J. Clin. Endocrinol. Metab. 99(2), E379–E383 (2014). https://doi.org/10.1210/jc.2013-2841

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the National Natural Science Foundation of China (numbers 81530026, 81970707, and 81830023).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tao Yang.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cai, Y., Xu, X., Zhang, Z. et al. Identification of novel HLA-A0201-restricted T-cell epitopes against thyroid antigens in autoimmune thyroid diseases. Endocrine 69, 562–570 (2020). https://doi.org/10.1007/s12020-020-02264-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02264-x

Keywords

Navigation